Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Biofil Chemicals & Pharmaceuticals Ltd Stock Analysis

Small Cap
Evaluated by 345 users | BSE: 524396 | NSE: BIOFILCHEM |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed 14.3%2.41%6.95%5.98%6.63%7.51%14.46%4%3.97%8.24%7.89%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 2.26.367.25.913.213.512.423.129.735.837
Y-o-Y Gr. Rt.-191.6%-4.2%19.3%-18.3%124.7%2.1%-8.1%87.1%28.4%20.4%-
Adjusted EPS (Rs.) 0.610.090.330.320.360.481.10.290.30.740.760.30
Y-o-Y Gr. Rt.--85.3%266.7%-3%12.5%33.3%129.2%-73.6%3.5%146.7%2.7%-
Book Value per Share (Rs.) 1.761.852.192.512.854.397.88.098.399.159.9110.15
Adjusted Net Profit 10.20.50.50.60.81.80.50.51.21.20
Net Op. Cash Flow (Rs. Cr.) -1.3-0.2-0.10.200.10.70.51.30.91.1-
Debt to Cash Flow from Ops -1.04-11.97-21.7513.59325.5710.022.013.361.31.330.39-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Biofil Chemicals & Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 21.3%22.1%42.5%20.4%
Adjusted EPS 26.8%9.6%37.9%2.7%
Book Value per Share 20.517.778.3
Share Price 24.9% 52.2% 94.4% -72.3%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) 23.532.227.646.797.218.115.23.643.68.467.992.99
Operating Profit Margin (%) -51.66.2616.8213.4812.526.6119.487.574.436.144.474.62
Net Profit Margin (%) 46.092.49.027.210.025.9413.343.812.094.073.471.34
Debt to Equity 0.450.820.790.70.640.190.110.120.120.080.030
Working Capital Days 237191272240306271371397223282281184
Cash Conversion Cycle -263-49-32051433113968516548
Loading price chart...
Entity Percentage Holding
Promoters 46.82%
Institutions 0.08%
Non-Institutions 53.10%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Biofil Chemicals & Pharmaceuticals Ltd's earnings have grown by 9.6%, whereas share price has appreciated 52.2% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Biofil Chemicals & Pharmaceuticals Ltd share price has appreciated 24.9% annually (CAGR) over the past ten years.

Data is not available for this company.

Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Its plant is located at Plot No. 8, Sector-IV Kheda Industrial Estate, Pithampur, Dhar District, Madhya

Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Its plant is located at Plot No. 8, Sector-IV Kheda Industrial Estate, Pithampur, Dhar District, Madhya Pradesh. The facility has received GMP certificate from Licensing Authority, Food & Drugs Administration, Department of Health and Government of Madhya Pradesh, India.

The manufacturing unit exports around 30 to 40% of their formulation directly or through merchant export to countries in own or neutral labels.

The shares of companies are listed on Bombay Stock Exchange.

Company exports its products to countries namely Kenya, Uganda, Tanzania, Nigeria, U.A.E, Rwanda, Monrovia, Republic of Yemen and Mauritius.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback